CLINICAL_TRIALS
trial_result
· 2020-01-06
Clinical Trial Update: Evaluation of rGH Therapy to Prevent Muscle Atrophy in Patients With ACL Tears [Phase 2]
Summary
Phase 2 clinical trial evaluating recombinant growth hormone therapy to prevent muscle atrophy after ACL tear.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Michigan | Conditions: Rupture of Anterior Cruciate Ligament | Phase 2 | Status: COMPLETED | Results posted: 2020-01-06